Improving access to essential tests for infectious diseases

Mikashmi Kohli; Paulami Sen; Madhukar Pai

doi:10.1016/j.micinf.2018.08.003

Improving access to essential tests for infectious diseases

Microbes Infect. 2019 Jan-Feb;21(1):1-3. doi: 10.1016/j.micinf.2018.08.003. Epub 2018 Sep 11.

Authors

Mikashmi Kohli¹, Paulami Sen¹, Madhukar Pai²

Affiliations

¹ McGill International Tuberculosis Centre, McGill University, Montreal, Canada.
² McGill International Tuberculosis Centre, McGill University, Montreal, Canada; Manipal McGill Centre for Infectious Diseases, Manipal Academy of Higher Education, Manipal, India. Electronic address: madhukar.pai@mcgill.ca.

PMID: 30217736
DOI: 10.1016/j.micinf.2018.08.003

Abstract

Recently, WHO published the first ever Essential Diagnostics List (EDL), which includes 113 tests, including tests for HIV, TB, malaria, hepatitis B and C, human papillomavirus (HPV) and syphilis. The EDL is a welcome first step in ensuring that diagnostics are a key part of all health systems. The impact of the list, however, will depend greatly on how countries adopt and implement the EDL.

Publication types

Editorial

MeSH terms

Communicable Diseases / diagnosis*
Delivery of Health Care / standards*
Diagnostic Techniques and Procedures / standards*
Guidelines as Topic
Humans
Laboratories / standards
World Health Organization